Screener
UroGen Pharma URGN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable and accrued expenses | $39,945 | $27,717 |
| Employee related accrued expenses | 12,253 | 13,516 |
| Current liabilities related to finance leases | 1,411 | 1,274 |
| Current liabilities related to operating leases | 684 | 481 |
| Other current liabilities | 7,622 | 3,430 |
| Total current liabilities | 61,915 | 46,418 |
| Non-current liabilities: | ||
| Prepaid forward obligation | 125,135 | 127,276 |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's operating lease liabilities (current)?
- UroGen Pharma (URGN) reported operating lease liabilities (current) of $684K in Q2 2026.
- How has UroGen Pharma's operating lease liabilities (current) changed year-over-year?
- UroGen Pharma's operating lease liabilities (current) increased by 2.4% year-over-year, from $668K to $684K.
- What is the long-term trend for UroGen Pharma's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), UroGen Pharma's operating lease liabilities (current) has grown at a -16.7% compound annual growth rate (CAGR), from $1.2M to $481K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about UroGen Pharma's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude